公司资料
VYNE Therapeutics Inc. 股价、新闻与催化剂
- 股票代码:
- VYNE
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
28.56 USD (+12.22%)
收盘价
最后更新: 2026年7月27日
22.5M USD
市值
股价为何变动
Current closing-price context is not available for VYNE.
公司概览
业务概览
VYNE Therapeutics is a dermatology and immunology company focused on skin disease and inflammatory biology. Its story is built around developing specialized therapies for dermatologic conditions.
所在地与行业分类
VYNE is headquartered in the United States and listed on NASDAQ. It sits in specialty dermatology biotechnology.
商业模式特征
The company depends on clinical progress, formulation or mechanism differentiation, and capital efficiency. Investors typically watch data updates and the company's ability to sharpen its dermatology franchise.
生物医药行业定位
VYNE occupies a focused dermatology niche within biotech. The stock is driven by whether its skin-disease programs can create durable differentiation.
未来催化剂
- VYNE’s catalysts are dermatology and immunology programs, plus any update that shows the company can still keep the story alive. The stock remains early-stage and data-dependent.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。